TABLE 2.
Various (unadjusted) outcome endpoints
| Outcome endpoint | % of patients |
P valuec | ||
|---|---|---|---|---|
| Overall (n = 109) | MDSa (n = 84) | MDRb (n = 25) | ||
| 30-day mortality | 18.3 | 11.9 | 40.0 | 0.003 |
| Hospital (all-cause) mortality | 25.7 | 16.7 | 56.0 | <0.001 |
| Infection-related mortality | 19.3 | 9.5 | 52.0 | <0.001 |
| Inappropriate empirical therapy | 14.7 | 6.0 | 44.0 | <0.001 |
| Mean length of hospital stay associated with bacteremia (days) ± SD | 18.7 ± 25.0 | 16.5 ± 23.6 | 26.4 ± 28.3 | 0.120 |
a
MDS, multidrug susceptible.
b
MDR, multidrug resistant.
c
By comparison of the multidrug-susceptible and multidrug-resistant cohorts.